v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (1,345,543) $ (1,679,220)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 427 60,527
Amortization of right to use assets 12,568 11,017
Amortization of patent rights 51,150 51,150
Depreciation expense 42,518 10,298
Non-cash interest revenue (6,879) (13,271)
Loss on change in fair value of profit share 245,681 353,351
Changes in operating assets and liabilities    
Accounts receivable (132,863) 558,223
Inventory (146,062) 29,643
Prepaid expenses and other assets 43,652 58,073
Accrued salaries 24,471 12,388
Accounts payable and accrued liabilities (984,095) 303,632
Operating lease liability (11,878) (10,146)
Net cash used in operating activities (2,206,853) (254,335)
Cash flows used in investing activities    
Purchase of property and equipment 0 (14,153)
Net cash used in investing activities 0 (14,153)
Cash flows from financing activities    
Proceeds from the issuance of common shares 16,440,000 0
Share issuance costs (1,730,133) 0
Net cash provided by financing activities 14,709,867 0
Net increase (decrease) in cash and cash equivalents 12,503,014 (268,488)
Cash and cash equivalents - beginning of period 2,245,426 3,456,082
Cash and cash equivalents - end of period 14,748,440 3,187,594
Cash paid during the period for:    
Interest 0 0
Income taxes 357 14,135
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING AND INVESTING ACTIVITIES    
Deferred financing costs reclassified to APIC upon issuance of common shares $ 481,250 $ 0

Source